These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 9438165)
21. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Blostein MD; Paltiel OB; Thibault A; Rybka WB Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007 [TBL] [Abstract][Full Text] [Related]
22. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800 [TBL] [Abstract][Full Text] [Related]
23. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Salat C; Holler E; Reinhardt B; Kolb HJ; Seeber B; Ledderose G; Mittermueller J; Duell T; Wilmanns W; Hiller E Bone Marrow Transplant; 1994 Nov; 14(5):747-50. PubMed ID: 7889007 [TBL] [Abstract][Full Text] [Related]
24. Veno-occlusive disease in pediatric patients after hematopoietic stem cell transplantation: relevance of activated coagulation and fibrinolysis markers and natural anticoagulants. Jevtic D; Zecevic Z; Veljkovic D; Dopsaj V; Radojicic Z; Elezovic I J Pediatr Hematol Oncol; 2011 Apr; 33(3):227-34. PubMed ID: 21336167 [TBL] [Abstract][Full Text] [Related]
25. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation]. Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053 [TBL] [Abstract][Full Text] [Related]
26. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation. Morio S; Oh H; Hirasawa A; Aotsuka N; Nakamura H; Asai T; Yoshida S; Ito M Bone Marrow Transplant; 1991 Aug; 8(2):147-9. PubMed ID: 1933057 [TBL] [Abstract][Full Text] [Related]
27. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients. Leblond V; Salehian BD; Borel C; Mapakou CP; Dombret H; Sutton L; Binet JL; Ankri A Bone Marrow Transplant; 1993 Apr; 11(4):299-305. PubMed ID: 8485478 [TBL] [Abstract][Full Text] [Related]
28. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation. Iguchi A; Kobayashi R; Kaneda M; Kobayashi K Pediatr Blood Cancer; 2010 Mar; 54(3):437-43. PubMed ID: 19911420 [TBL] [Abstract][Full Text] [Related]
29. Early hemostatic alterations following bone marrow transplantation: a prospective study. Vannucchi AM; Rafanelli D; Longo G; Bosi A; Guidi S; Saccardi R; Filimberti E; Cinotti S; Grossi A; Morfini M Haematologica; 1994; 79(6):519-25. PubMed ID: 7896209 [TBL] [Abstract][Full Text] [Related]
30. Endothelium and bone marrow transplantation. Catani L; Gugliotta L; Vianelli N; Nocentini F; Baravelli S; Bandini G; Cirio TM; Tura S Bone Marrow Transplant; 1996 Feb; 17(2):277-80. PubMed ID: 8640179 [TBL] [Abstract][Full Text] [Related]
31. Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate. Patton DF; Harper JL; Wooldridge TN; Gordon BG; Coccia P; Haire WD Bone Marrow Transplant; 1996 Mar; 17(3):443-7. PubMed ID: 8704704 [TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068 [TBL] [Abstract][Full Text] [Related]
33. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation. Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625 [TBL] [Abstract][Full Text] [Related]
34. Parenteral glutamine protects hepatic function during bone marrow transplantation. Brown SA; Goringe A; Fegan C; Davies SV; Giddings J; Whittaker JA; Burnett AK; Poynton CH Bone Marrow Transplant; 1998 Aug; 22(3):281-4. PubMed ID: 9720743 [TBL] [Abstract][Full Text] [Related]
35. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Rio B; Bauduer F; Arrago JP; Zittoun R Bone Marrow Transplant; 1993 Jun; 11(6):471-2. PubMed ID: 8334428 [TBL] [Abstract][Full Text] [Related]
36. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Toh HC; McAfee SL; Sackstein R; Cox BF; Colby C; Spitzer TR Bone Marrow Transplant; 1999 Oct; 24(8):891-5. PubMed ID: 10516702 [TBL] [Abstract][Full Text] [Related]
37. [Veno-occlusive disease of the liver]. Rybicka M; Krysiak R; Okopień B Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257 [TBL] [Abstract][Full Text] [Related]
38. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation. Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502 [TBL] [Abstract][Full Text] [Related]
39. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation. Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075 [TBL] [Abstract][Full Text] [Related]
40. Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients. Essell JH; Thompson JM; Harman GS; Halvorson RD; Snyder MJ; Callander NS; Clement DJ Bone Marrow Transplant; 1992 Oct; 10(4):367-72. PubMed ID: 1422493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]